Cost Analysis of Adjuvant Whole-Brain Radiotherapy Treatment Versus No Whole-Brain Radiotherapy After Stereotactic Radiosurgery and/or Surgery Among Adults with One to Three Melanoma Brain Metastases: Results from a Randomized Trial

被引:0
|
作者
Anh Dam Tran
Angela M. Hong
Mai T. H. Nguyen
Gerald Fogarty
Victoria Steel
Elizabeth Paton
Rachael L. Morton
机构
[1] UNSW,National Drug and Alcohol Research Centre
[2] The University of Sydney,NHMRC Clinical Trials Centre, Faculty of Medicine and Health
[3] The University of Sydney,Melanoma Institute of Australia
[4] The University of Sydney,Sydney Medical School
[5] St Vincent’s Clinic,Genesis Cancer Care
[6] Monash University,Melanoma and Skin Cancer Trials
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:587 / 594
页数:7
相关论文
共 50 条
  • [1] Cost Analysis of Adjuvant Whole-Brain Radiotherapy Treatment Versus No Whole-Brain Radiotherapy After Stereotactic Radiosurgery and/or Surgery Among Adults with One to Three Melanoma Brain Metastases: Results from a Randomized Trial
    Anh Dam Tran
    Hong, Angela M.
    Nguyen, Mai T. H.
    Fogarty, Gerald
    Steel, Victoria
    Paton, Elizabeth
    Morton, Rachael L.
    [J]. PHARMACOECONOMICS-OPEN, 2022, 6 (04) : 587 - 594
  • [2] Cost-Effectiveness of Subsequent Whole-Brain Radiotherapy or Hippocampal-Avoidant Whole-Brain Radiotherapy Versus Stereotactic Radiosurgery or Surgery Alone for Treatment of Melanoma Brain Metastases
    Anh Dam Tran
    Gerald Fogarty
    Anna K. Nowak
    Vakaramoko Diaby
    Angela Hong
    Caroline Watts
    Rachael L. Morton
    [J]. Applied Health Economics and Health Policy, 2020, 18 : 679 - 687
  • [3] Cost-Effectiveness of Subsequent Whole-Brain Radiotherapy or Hippocampal-Avoidant Whole-Brain Radiotherapy Versus Stereotactic Radiosurgery or Surgery Alone for Treatment of Melanoma Brain Metastases
    Anh Dam Tran
    Fogarty, Gerald
    Nowak, Anna K.
    Diaby, Vakaramoko
    Hong, Angela
    Watts, Caroline
    Morton, Rachael L.
    [J]. APPLIED HEALTH ECONOMICS AND HEALTH POLICY, 2020, 18 (05) : 679 - 687
  • [4] Stereotactic radiosurgery with or without whole-brain radiotherapy for brain metastases: an update
    Park, Henry S.
    Chiang, Veronica L.
    Knisely, Jonathan P.
    Raldow, Ann C.
    Yu, James B.
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2011, 11 (11) : 1731 - 1738
  • [5] Biological implications of whole-brain radiotherapy versus stereotactic radiosurgery of multiple brain metastases
    Xue, Jinyu
    Kubicek, Gregory J.
    Grimm, Jimm
    LaCouture, Tamara
    Chen, Yan
    Goldman, H. Warren
    Yorke, Ellen
    [J]. JOURNAL OF NEUROSURGERY, 2014, 121 : 60 - 68
  • [6] A MATCHED-PAIR ANALYSIS COMPARING WHOLE-BRAIN RADIOTHERAPY PLUS STEREOTACTIC RADIOSURGERY VERSUS SURGERY PLUS WHOLE-BRAIN RADIOTHERAPY AND A BOOST TO THE METASTATIC SITE FOR ONE OR TWO BRAIN METASTASES
    Rades, Dirk
    Kueter, Jan-Dirk
    Pluemer, Andre
    Veninga, Theo
    Schild, Steven E.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 73 (04): : 1077 - 1081
  • [7] WHOLE-BRAIN RADIOTHERAPY VERSUS STEREOTACTIC RADIOSURGERY IN CEREBRAL LUNG CANCER METASTASES
    Sagerup, C. M.
    Hovik, B. H.
    Helland, A.
    Brustugun, O. T.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (05) : S96 - S96
  • [8] Radiosurgery alone or in combination with whole-brain radiotherapy for brain metastases
    Pirzkall, A
    Debus, J
    Lohr, F
    Fuss, M
    Rhein, B
    Engenhart-Cabillic, R
    Wannenmacher, M
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (11) : 3563 - 3569
  • [9] Cost-effectiveness of stereotactic radiosurgery with and without whole-brain radiotherapy for the treatment of newly diagnosed brain metastases
    Hall, Matthew D.
    McGee, James L.
    McGee, Mackenzie C.
    Hall, Kevin A.
    Neils, David M.
    Klopfenstein, Jeffrey D.
    Elwood, Patrick W.
    [J]. JOURNAL OF NEUROSURGERY, 2014, 121 : 84 - 90
  • [10] Should patients with melanoma brain metastases receive adjuvant whole-brain radiotherapy?
    Fogarty, Gerald B.
    Hong, Angela
    Thompson, John F.
    [J]. LANCET ONCOLOGY, 2015, 16 (05): : E195 - E196